Outset Medical, Inc. (OM)
Stock Price:
$60.39 USD
-3.36 (-5.27%)
Updated November 25, 4:00 PM EST - Market closed
Key Info
| Market Cap |
2.58B |
| Revenue (ttm) |
39.77M |
| Net Income (ttm) |
-108.89M |
| Shares Out |
42.70M |
| EPS (ttm) |
-2.55 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 25 |
| Last Price |
$60.39 |
| Previous Close |
$63.75 |
| Change ($) |
-3.36 |
| Change (%) |
-5.27% |
| Day's Open |
57.35 |
| Day's Range |
57.10 - 63.38 |
| Day's Volume |
331,974 |
| 52-Week Range |
42.50 - 66.96 |
More Stats
| Market Cap |
2.58B |
| Enterprise Value |
2.24B |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
42.70M |
| Float |
30.10M |
| EPS (basic) |
n/a |
| EPS (diluted) |
-2.55 |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
742,396 |
| Short Ratio |
2.93 |
| Short % of Float |
2.47% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
64.84 |
| PB Ratio |
7.41 |
| Revenue |
39.77M |
| Operating Income |
n/a |
| Net Income |
-108.89M |
| Free Cash Flow |
n/a |
| Net Cash |
338.78M |
| Net Cash / Share |
7.93 |
| Gross Margin |
-44.76% |
| Operating Margin |
n/a |
| Profit Margin |
-143.47% |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (5)
| Buy |
4 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$55.40*
(-8.26% downside)
Low
48.0
Current: $60.39
High
60.0
Target: 55.40
*Average 12-month price target from 5 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 |
|---|
| Revenue | 15.08 | 2.01 |
| Revenue Growth | 651.27% | - |
| Gross Profit | -17.80 | -6.12 |
| Operating Income | -70.31 | -46.56 |
| Net Income | -68.30 | -49.78 |
| Shares Outstanding | 6.78 | 5.73 |
| Earnings Per Share | -12.60 | -12.75 |
| Operating Cash Flow | -70.29 | -46.44 |
| Capital Expenditures | -3.29 | -1.77 |
| Free Cash Flow | -73.59 | -48.21 |
| Cash & Equivalents | 70.08 | 143 |
| Total Debt | 29.06 | 28.36 |
| Net Cash / Debt | 41.02 | 114 |
| Assets | 88.37 | 151 |
| Liabilities | 51.11 | 49.80 |
| Book Value | -372 | -288 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Outset Medical, Inc. |
| Country |
United States |
| Employees |
284 |
| CEO |
Leslie L. Trigg |
Stock Information
| Ticker Symbol |
OM |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: OM |
| IPO Date |
September 15, 2020 |
Description
Outset Medical, a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo, a dialysis machine that enables dialysis care in acute and chronic settings. The Tablo comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.